Article
Sieve analysis in HIV-1 vaccine efficacy trials.
Current opinion in HIV and AIDS - 1 Sept 2013
Edlefsen Paul T, Gilbert Peter B, Rolland Morgane
Abstract excerpt
PURPOSE OF REVIEW: The genetic characterization of HIV-1 breakthrough infections in vaccine and placebo recipients offers new ways to assess vaccine efficacy trials. Statistical and sequence analysis methods provide opportunities to mine the mechanisms behind the effect of an HIV vaccine. RECENT FINDINGS: The release of results from two HIV-1 vaccine efficacy trials, Step/HVTN-502 (HIV Vaccine Trials Network-502)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
